Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Nirsevimab (Beyfortus) Guide to Prevent Severe RSV in Infants and Toddlers
This one-page infographic provides guidance on using nirsevimab (Beyfortus) to prevent severe RSV in infants and toddlers. It addresses high-risk conditions in children, as well …
Ask aRCie
Beyfortus® For Prevention of Respiratory Syncytial Virus (RSV) in Infants
This webpage provides a pharmacy update on the use of Beyfortus for the prevention of RSV in infants. The FDA approved nirsevimab for infants and …
Guidelines for Inpatient Administration of Nirsevimab to Infants and Children
2024
· University of Michigan
This 4-page document explain how to give nirsevimab to infants and children in hospitals. It describes dosing based on age and weight, especially after heart …
Vaccine Resources: Nirsevimab Effectiveness, AI in Health Communication and Updated VISs
This post is about vaccine resources, focusing on the effectiveness of nirsevimab, a medication used to prevent respiratory infections in infants. It describes how artificial …
News & Views: Nirsevimab Means Brushing Up on Passive Immunity Talking Points
This post is about nirsevimab, a new treatment that helps protect babies from respiratory illnesses. It describes how nirsevimab provides passive immunity, which means it …
New Monoclonal Antibody Prevents RSV in Infants and Toddlers
This article discusses the approval of the monoclonal antibody nirsevimab-alip (Beyfortus) to prevent respiratory syncytial virus (RSV) in high-risk neonates and infants up to 24 …
Monoclonal Antibody 75% Effective in Infants Against Respiratory Viral Infection
2022
This article describes a study on nirsevimab, a monoclonal antibody that could protect infants from RSV infections. The study involved 1,490 infants and showed that …
Game Over for RSV?
2023
· Yale University
This letter comments on a study by D. Wilkins and colleagues and concludes that passive immunization with nirsevimab protects infants from severe respiratory syncytial virus …
Evaluation of Antibody-Based Preventive Alternatives for Respiratory Syncytial Virus: A Novel Multi-Criteria Decision Analysis Framework and Assessment of Nirsevimab in Spain
2024
· University Carlos III,
· BioMad,
· Fisabio-Public Health,
· Catholic University of Valencia,
· Instituto de Salud Carlos III,
· Weber Foundation
This study evaluates nirsevimab, an antibody-based preventive measure for respiratory syncytial virus (RSV) in Spain. Using a multi-criteria decision analysis framework, experts found that nirsevimab …
Nirsevimab Immunization to Prevent Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants and Children up to 24 Months of Age
This article discusses nirsevimab, its side effects, and its implications for the nursing field. Respiratory syncytial virus (RSV) is a common virus infecting infants, causing …